Ranked #1 Children's Hospital by U.S. News & World Report
MyPatients provides referring primary care providers with secure access to their patients’ information.
Boston Children's has launched the world's 1st program dedicated to offering hand transplants to children who qualify.
Innovation insider is a semi-monthly e-newsletter analyzes innovations at Boston Children’s, other academic medical centers and from industry.
Read the latest blog by a Boston Children's doctor, clinician or staff member.
There are many ways you can help children and their families get the care they need.
Boston Children’s Hospital is home to the world’s most extensive research enterprise at a pediatric hospital.
The Atopic Dermatitis Center, a program within the Division of Allergy and Immunology at Children’s, develops treatments informed by research. Lynda Schneider, MD, is a principal investigator for the NIH Atopic Dermatitis Research Network (ADRN) which is focused on atopic dermatitis (AD) and its association with both immune and skin barrier defects. (ADRNStudy@childrens.harvard.edu) Dr. Schneider is also an investigator for a long term study of children who have used topical tacrolimus ointment.
Food Allergy Research
Dr. Lynda Schneider, MD and Dr. Rima Rachid, MD are conducting studies to evaluate desensitization for peanut allergy in children and young adults. If you or your child are interested in participating contact 617-355-6127.
The Asthma Clinical Research Center at Children’s Hospital Boston conducts numerous asthma research studies for all ages. For more information on current studies, please visit AsthmaNet or the Severe Asthma Research Program
During your visit to the Allergy and Asthma Program at Children’s, you may be asked if you are willing to have your child participate in a clinical research study or clinical trial. All clinical research is approved by the Children’s Hospital Institutional Review Board (IRB) and is always voluntary.
If you or your child is interested in participating, please email Asthma@childrens.harvard.edu or call 857-218-5336
In addition our division conducts research in drug allergy, hereditary angioedema, and primary immunodeficiency.
The future of pediatrics will be forged by thinking differently, breaking paradigms and joining together in a shared vision of tackling the toughest challenges before us.”